DRMA Leads Health Care Gainers
Dermata Therapeutics stock rises 44.4% to $1.56 after Q2 earnings report
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.